MPEDA to organise Second National Seafood Skill Olympiad during Seafood Expo Bharat 2026 (See 'Corp Brief') India's Space and Biotechnology Sectors present new collaboration opportunities: MoS (See 'Corp Brief') IPR - After pronouncement of final judgment and decree under Order XX CPC, Court becomes functus officio and cannot grant liberty for post-decree impleadment of mirror/redirect/alphanumeric websites: HC (See 'Legal Desk') Office of Principal Scientific Adviser signs MoU with Data Security Council of India (See 'Corp Brief') Telangana strengthens Clean Cities Through Behaviour Change and Citizen Action (See 'Corp Brief') IPR - If essential and dominant feature of earlier mark is fully contained in later mark, and later mark is only pluralized form that conveys same meaning, later mark can be held deceptively similar: HC (See 'Legal Desk') JP Nadda To Release Guidelines For 'Anaemia Mukt Bharat Abhiyaan' Today (See 'Corp Brief') A&C - Restraint on alienation of assets cannot be imposed when such relief was neither specifically sought nor argued in Section 17 application: HC (See 'Legal Desk') Environment Minister inaugurates workshop on tiger reintroduction in Sariska (See 'Corp Brief') JP Nadda to unveil healthcare programme for children up to three years (See 'Corp Brief') A&C - Scope of scrutiny u/s 11 is confined to prima facie examination of existence of arbitration agreement & does not extend to adjudication of disputed questions of fact or law: HC (See 'Legal Desk') Dasheri, Chausa, Langra and Kesar showcase Rich Diversity of Indian Mangoes (See 'Corp Brief') FEMA - Statutory protection under Section 6(4) cannot be invoked to legitimise unexplained or inadequately accounted foreign exchange transactions: SAFEMA (See 'Legal Desk') Ease of Doing Business: Irritants eased out of FSSAI Licensing Regulations (See 'Corp Brief') SEBI - Failure to file Quarterly Activity Reports for multiple consecutive quarters constitutes violation of regulatory framework & attracts consequences prescribed under Regulation 35 of AIF Regulations, 2012: SEBI (See 'Legal Desk') AI, Nuclear, Space, Quantum tech to determine contours of future growth: MoS (See 'Corp Brief') SARFAESI - In absence of any adjudication by the DRT in determining the debt, statutory scheme permits reliance upon claim made by secured creditor for purpose of fixing pre-deposit: HC (See 'Legal Desk') Tech Innovation and disruption in Construction Industry (See 'CORP EINSICHT')

India's First Ferret Research Facility dedicated to Nation

Published: Feb 04, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 04, 2025: INDIA'S commitment to cutting-edge biomedical research and innovation took a significant leap forward with the dedication of the nation's first Ferret Research Facility, the launch of the GARBH-INi-DRISHTI data repository, and the execution of a key technology transfer agreement. The events, held at the Translational Health Science and Technology Institute (THSTI) in the NCR Biotech Science Cluster, Faridabad, Haryana, were presided over by Dr. Rajesh Gokhale, Director General, Biotechnology Research and Innovation Council and Secretary, Department of Biotechnology on 3rd Feb 2025.

The newly inaugurated THSTI Ferret Research Facility, a state-of-the-art establishment adhering to the highest biosafety and research standards, marks a pivotal moment in India's fight against infectious and non-communicable diseases. This pioneering facility will serve as a crucial resource for vaccine development, therapeutic testing, and research into emerging infectious diseases, significantly bolstering India's pandemic preparedness strategy and positioning the nation at the forefront of global scientific endeavors.

Dr. Gokhale also launched GARBH-INi-DRISHTI, the DBT Data Repository and Information Sharing Hub at THSTI. This groundbreaking platform, developed under the GARBH-INi program, provides access to an unprecedented wealth of clinical data, images, and biospecimens collected from over 12,000 pregnant women, newborns, and postpartum mothers. As one of South Asia's largest maternal and child health databases, GARBH-INi-DRISHTI will empower researchers worldwide to conduct transformative research aimed at improving maternal and neonatal health outcomes. Its foundation lies in collaborative efforts across India's leading research institutions and hospitals, representing a powerful synergy of expertise.

Furthering the drive to translate research into tangible benefits, THSTI executed a Technology Transfer Agreement with M/s Sundyota Numandis Probioceuticals Pvt. Ltd. This agreement facilitates the commercialization of THSTI's innovative, genetically defined synthetic microbial consortium, Lactobacillus crispatus . Isolated from the reproductive tracts of women enrolled in the GARBH-INi cohort, this consortium holds immense promise for nutraceutical applications, promoting overall health and well-being through targeted microbiome-based interventions.

Prof. GanesanKarthikeyan, Executive Director of THSTI, highlighted the institute's strategic role in shaping India's biotech ecosystem, emphasizing its contributions to fostering a robust environment for research and commercialization.

Dr. Gokhale lauded THSTI's commitment to translational research, recognizing the Ferret Facility as a landmark achievement placing India among select nations with such capabilities. He commended the development of GARBH-INi-DRISHTI, emphasizing its potential to empower researchers nationwide in improving birth outcomes. Dr. Gokhale also underscored the importance of technology transfer agreements in driving the biomanufacturing ecosystem and applauded THSTI's efforts in forging industry partnerships for commercialization. These combined initiatives represent a powerful confluence of scientific advancement, data-driven research, and industry collaboration, propelling India towards a healthier and more prosperous future.

TIOL CORP SEARCH

TIOL GROUP WEBSITES